Ani Pharmaceuticals Inc SEC filings ANIP
Ani Pharmaceuticals Inc has 1,002 filings in SEC EDGAR's recent list, going back to Nov 3, 2014. Its latest annual report, Form ARS, was filed on Apr 9, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 24, 2026 | Aug 19, 2026 |
| 10-Q | Quarterly report | Aug 7, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 7, 2026 | Aug 7, 2026 |
| S-8 | Employee stock plan registration | Jul 17, 2026 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 21, 2026 | May 21, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
May 13, 2026 | May 13, 2026 |
| 10-Q | Quarterly report | May 8, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 8, 2026 | May 8, 2026 |
| ARS | Annual report to shareholders | Apr 9, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 9, 2026 | — |
| DEF 14A | Proxy statement | Apr 9, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Auditor change
|
Apr 7, 2026 | Apr 1, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 3, 2026 | Mar 3, 2026 |
| 10-K | Annual report | Feb 27, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 27, 2026 | Feb 27, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 12, 2026 | Jan 12, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Dec 1, 2025 | Nov 24, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 10, 2025 | Nov 10, 2025 |
| 10-Q | Quarterly report | Nov 7, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2025 | Nov 7, 2025 |
| 8-K |
Current report
Unregistered share sale, Change to shareholder rights
|
Sep 26, 2025 | Sep 26, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Sep 8, 2025 | Sep 8, 2025 |
| 10-Q | Quarterly report | Aug 8, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2025 | Aug 8, 2025 |
| 8-K |
Current report
Other events
|
Jul 29, 2025 | Jul 29, 2025 |
| 8-K |
Current report
Other events
|
Jul 23, 2025 | Jul 23, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Jul 23, 2025 | Jul 23, 2025 |
| S-8 | Employee stock plan registration | Jul 11, 2025 | — |
| S-8 | Employee stock plan registration | Jul 11, 2025 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jun 4, 2025 | Jun 4, 2025 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
May 23, 2025 | May 22, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 20, 2025 | May 20, 2025 |
| 10-Q | Quarterly report | May 9, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 9, 2025 | May 9, 2025 |
| DEFA14A | Additional proxy material | May 8, 2025 | — |
| 8-K |
Current report
Other events
|
May 8, 2025 | May 6, 2025 |
| ARS | Annual report to shareholders | Apr 10, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 10, 2025 | — |
| DEF 14A | Proxy statement | Apr 10, 2025 | Dec 31, 2024 |
| PRE 14A | Preliminary proxy statement | Mar 31, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Other events
|
Mar 18, 2025 | Mar 18, 2025 |
| 8-K |
Current report
Other events
|
Mar 14, 2025 | Mar 14, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 11, 2025 | Mar 11, 2025 |
| 10-K | Annual report | Feb 28, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 28, 2025 | Feb 28, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 5, 2025 | Feb 5, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 20, 2024 | Nov 20, 2024 |
| 10-Q | Quarterly report | Nov 8, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2024 | Nov 8, 2024 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets
|
Sep 20, 2024 | Sep 16, 2024 |
| 8-K |
Current report
Other events
|
Sep 16, 2024 | Sep 16, 2024 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt, Unregistered share sale, Other events
|
Aug 13, 2024 | Aug 7, 2024 |
| 8-K |
Current report
Other events
|
Aug 8, 2024 | Aug 7, 2024 |
| 8-K |
Current report
Other events
|
Aug 7, 2024 | Aug 7, 2024 |
| 10-Q | Quarterly report | Aug 6, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2024 | Aug 6, 2024 |
| S-8 | Employee stock plan registration | Jul 12, 2024 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Jun 24, 2024 | Jun 21, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jun 5, 2024 | Jun 5, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 23, 2024 | May 21, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 14, 2024 | May 14, 2024 |
| 10-Q | Quarterly report | May 10, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 10, 2024 | May 10, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Apr 17, 2024 | Apr 17, 2024 |
| ARS | Annual report to shareholders | Apr 5, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 5, 2024 | — |
| DEF 14A | Proxy statement | Apr 5, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 12, 2024 | Mar 12, 2024 |
| 10-K | Annual report | Feb 29, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 29, 2024 | Feb 29, 2024 |
| 8-K |
Current report
Material agreement
|
Feb 23, 2024 | Feb 16, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 8, 2024 | Feb 8, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 8, 2024 | Jan 8, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 15, 2023 | Nov 15, 2023 |
| 10-Q | Quarterly report | Nov 8, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2023 | Nov 8, 2023 |
| 8-K |
Current report
Other events
|
Oct 2, 2023 | Oct 2, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Sep 25, 2023 | Sep 25, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Sep 12, 2023 | Sep 11, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Sep 7, 2023 | Sep 7, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 30, 2023 | Aug 30, 2023 |
| 8-K |
Current report
Officer or director change
|
Aug 23, 2023 | Aug 21, 2023 |
| 10-Q | Quarterly report | Aug 9, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2023 | Aug 9, 2023 |
| S-8 | Employee stock plan registration | Jun 23, 2023 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jun 9, 2023 | Jun 9, 2023 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 25, 2023 | May 23, 2023 |
| 8-K |
Current report
Other events
|
May 16, 2023 | May 16, 2023 |
| 424B5 | Prospectus supplement | May 12, 2023 | — |
| 8-K |
Current report
Material agreement, Other events
|
May 12, 2023 | May 11, 2023 |
| 8-K |
Current report
Other events
|
May 11, 2023 | May 11, 2023 |
| 424B5 | Prospectus supplement | May 11, 2023 | — |
| DEFA14A | Additional proxy material | May 8, 2023 | — |
| 8-K |
Current report
Officer or director change, Other events
|
May 8, 2023 | May 7, 2023 |
| 10-Q | Quarterly report | May 8, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 8, 2023 | May 8, 2023 |
| DEFA14A | Additional proxy material | Apr 11, 2023 | — |
| DEF 14A | Proxy statement | Apr 11, 2023 | — |
| ARS | Annual report to shareholders | Apr 11, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 10, 2023 | Mar 10, 2023 |
| 10-K | Annual report | Mar 9, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 9, 2023 | Mar 9, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Mar 6, 2023 | Feb 28, 2023 |
| CT ORDER | Filing | Feb 22, 2023 | — |
| UPLOAD | Letter from the SEC | Jan 30, 2023 | — |
| CORRESP | Letter to the SEC | Jan 27, 2023 | — |
| CORRESP | Letter to the SEC | Jan 6, 2023 | — |
| UPLOAD | Letter from the SEC | Dec 12, 2022 | — |
| CORRESP | Letter to the SEC | Dec 5, 2022 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 9, 2022 | Nov 9, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2022 | Nov 9, 2022 |
| 10-Q | Quarterly report | Nov 9, 2022 | Sep 30, 2022 |
| UPLOAD | Letter from the SEC | Nov 1, 2022 | — |
| 10-Q | Quarterly report | Aug 8, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2022 | Aug 8, 2022 |
| 8-K/A |
Amended current report
Exit or restructuring costs
|
Aug 8, 2022 | Jun 2, 2022 |
| 8-K |
Current report
Exit or restructuring costs, Regulation FD disclosure
|
Jun 2, 2022 | Jun 2, 2022 |
| 10-Q | Quarterly report | May 10, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 10, 2022 | May 10, 2022 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Apr 29, 2022 | Apr 27, 2022 |
| S-8 | Employee stock plan registration | Apr 27, 2022 | — |
| DEFA14A | Additional proxy material | Apr 14, 2022 | — |
| DEF 14A | Proxy statement | Mar 25, 2022 | Apr 27, 2022 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 23, 2022 | Mar 19, 2022 |
| 10-K | Annual report | Mar 15, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 15, 2022 | Mar 15, 2022 |
| 8-K |
Current report
Officer or director change
|
Feb 28, 2022 | Feb 23, 2022 |
| 8-K |
Current report
Other events
|
Feb 15, 2022 | Feb 15, 2022 |
| 8-K |
Current report
Other events
|
Jan 24, 2022 | Jan 24, 2022 |
| 424B3 | Prospectus | Jan 19, 2022 | — |
| EFFECT | Filing | Jan 18, 2022 | — |
| CORRESP | Letter to the SEC | Jan 13, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 28, 2021 | — |
| S-3 | Shelf registration | Dec 17, 2021 | — |
| 8-K |
Current report
Material agreement, Agreement ended, Acquisition or sale of assets, New debt, Unregistered share sale, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
Nov 26, 2021 | Nov 19, 2021 |
| 424B5 | Prospectus supplement | Nov 5, 2021 | — |
| 8-K |
Current report
Material agreement
|
Nov 4, 2021 | Nov 3, 2021 |
| 424B5 | Prospectus supplement | Nov 3, 2021 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 3, 2021 | Nov 3, 2021 |
| S-8 | Employee stock plan registration | Nov 1, 2021 | — |
| 10-Q | Quarterly report | Nov 1, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 1, 2021 | Nov 1, 2021 |
| 10-Q | Quarterly report | Aug 6, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2021 | Aug 6, 2021 |
| 8-K |
Current report
Shareholder vote results, Regulation FD disclosure
|
Jun 4, 2021 | Jun 2, 2021 |
| DEFA14A | Additional proxy material | May 7, 2021 | — |
| 8-K |
Current report
Results of operations
|
May 7, 2021 | May 7, 2021 |
| 10-Q | Quarterly report | May 7, 2021 | Mar 31, 2021 |
| DEF 14A | Proxy statement | Apr 29, 2021 | Jun 2, 2021 |
| PRE 14A | Preliminary proxy statement | Apr 19, 2021 | Apr 19, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 6, 2021 | Apr 6, 2021 |
| 10-K | Annual report | Mar 11, 2021 | Dec 31, 2020 |
| DEFA14A | Additional proxy material | Mar 9, 2021 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Mar 9, 2021 | Mar 8, 2021 |
| DEFA14A | Additional proxy material | Mar 9, 2021 | — |
| 8-K |
Current report
Results of operations
|
Mar 9, 2021 | Mar 9, 2021 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Feb 17, 2021 | Feb 11, 2021 |
| S-8 | Employee stock plan registration | Nov 23, 2020 | — |
| 10-Q | Quarterly report | Nov 5, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2020 | Nov 5, 2020 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Aug 6, 2020 | Aug 5, 2020 |
| 10-Q | Quarterly report | Aug 6, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2020 | Aug 6, 2020 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Aug 3, 2020 | Aug 3, 2020 |
| EFFECT | Filing | Jul 17, 2020 | — |
| CORRESP | Letter to the SEC | Jul 16, 2020 | — |
| UPLOAD | Letter from the SEC | Jul 14, 2020 | — |
| S-3 | Shelf registration | Jul 9, 2020 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 11, 2020 | Jun 5, 2020 |
| 8-K |
Current report
Other events
|
Jun 1, 2020 | Jun 1, 2020 |
| DEFA14A | Additional proxy material | May 21, 2020 | — |
| CT ORDER | Filing | May 15, 2020 | — |
| 8-K |
Current report
Listing notice, Officer or director change
|
May 14, 2020 | May 8, 2020 |
| 8-K |
Current report
Results of operations, Officer or director change
|
May 7, 2020 | May 4, 2020 |
| 10-Q | Quarterly report | May 7, 2020 | Mar 31, 2020 |
| DEFA14A | Additional proxy material | Apr 30, 2020 | — |
| 8-K |
Current report
Results of operations
|
Apr 30, 2020 | Apr 30, 2020 |
| 8-K |
Current report
Other events
|
Apr 29, 2020 | Apr 29, 2020 |
| DEFA14A | Additional proxy material | Apr 23, 2020 | — |
| DEF 14A | Proxy statement | Apr 23, 2020 | Jun 5, 2020 |
| 8-K |
Current report
Officer or director change
|
Apr 14, 2020 | Apr 10, 2020 |
| CT ORDER | Filing | Apr 14, 2020 | — |
| CT ORDER | Filing | Apr 2, 2020 | — |
| CT ORDER | Filing | Apr 2, 2020 | — |
| 8-K |
Current report
Results of operations
|
Feb 27, 2020 | Feb 27, 2020 |
| 10-K | Annual report | Feb 27, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Results of operations
|
Feb 20, 2020 | Feb 20, 2020 |
| 8-K |
Current report
Officer or director change
|
Jan 22, 2020 | Jan 17, 2020 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets
|
Jan 9, 2020 | Jan 8, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 3, 2019 | Dec 3, 2019 |
| 8-K |
Current report
New debt
|
Dec 2, 2019 | Nov 29, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 26, 2019 | Nov 26, 2019 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2019 | Nov 6, 2019 |
| 10-Q | Quarterly report | Nov 6, 2019 | Sep 30, 2019 |
| 8-K |
Current report
Results of operations
|
Oct 30, 2019 | Oct 30, 2019 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2019 | Aug 7, 2019 |
| 10-Q | Quarterly report | Aug 7, 2019 | Jun 30, 2019 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ANIP (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Princeton, NJ
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1023024
- Former names
- BIOSANTE PHARMACEUTICALS INC (until Jul 18, 2013); BEN ABRAHAM TECHNOLOGIES INC (until Dec 23, 1999)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.